| Views | |
|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 98 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 2 | 14 | 2 | 14 | 2 | 1 | 1 |
| Views | |
|---|---|
| EMBR_EMBR202154305.pdf | 110 |
